Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Will High-Risk smokers keep up with lung scans? french study aims to find out

NCT ID NCT06020443

Knowledge-focused Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tracks 126 heavy smokers aged 50 to 74 in France to see how many complete a three-year lung cancer screening program using low-dose CT scans. Researchers also measure how many people quit smoking during the program. The goal is to understand real-world adherence, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
low-dose chest CT scan
What this could lead to
If successful, this could show how to improve participation in lung cancer screening programs, potentially catching more cancers early.
What could go wrong
This is an observational study, not testing a new treatment. It only measures adherence, so it won't directly prevent or cure lung cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 126 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 74 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 50 to 74 years * Smoking OR having smoked (withdrawal of \<15 years): ≥15 cigarettes/day for ≥25 years OR ≥10 cigarettes/day for ≥30 years * Affiliated or beneficiary of a social security scheme * Written informed consent Exclusion Criteria: * Inability to walk up two flights of stairs without stopping * BMI \> 35 kg/m² * Recent chest CT scan \< 1 year * Personal history of lung cancer \< 5 years or under treatment * Personal history of cancer being monitored by chest CT scan * Contraindication to lung cancer treatment or diagnostic investigations * Current or recent respiratory symptoms immediately suggestive of lung cancer * Pregnant or breast-feeding woman * Person under court protection, guardianship or curatorship * Person deprived of liberty by judicial or administrative decision.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for High-risk cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

lung cancer lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

High-risk cancer Lung cancer

Contacts and locations

Locations

  • Cabinet de médecine générale

    Colmar, Haut-Rhin, 68000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.